FIELD: pharmaceutical industry, in particular antacidal and purgative tablet.
SUBSTANCE: claimed tablet for peroral administration contains particles of magnesium oxide as active ingredient, wherein 1) magnesium oxide particles containing in tablet, have average secondary size measured by laser IR-scattering of 0.5-10 mum; 2) tablet contains 99 mass % or more of magnesium oxide particles: 3) tablet is not blacked and essentially has no spots formed in pelletization process; and 4) tablet disintegration time is 10 s or less.
EFFECT: tablets with high content of magnesium oxide particles and short disintegration time.
12 cl, 6 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTACID AND LAXATIVE TABLET | 2010 |
|
RU2501561C1 |
| ERYTHRITE TABLETING | 2009 |
|
RU2498636C2 |
| PILL AND CHISEL FOR IT | 2010 |
|
RU2517130C2 |
| TABLET SUBJECTING FOR RAPID DECOMPOSITION IN BUCCAL POCKET AND METHOD FOR ITS PREPARING | 2002 |
|
RU2244543C2 |
| METASILICATES OF CALCIUM AND WAYS OF THEIR OBTAINING | 2002 |
|
RU2343902C2 |
| NSAID PREPARATION CONTAINING GRANULATED COMPOSITION AND EXTRA-GRANULATED COMPOSITION | 2002 |
|
RU2298404C2 |
| TABLET, WHICH IS DECOMPOSED IN MOUTH | 2008 |
|
RU2478375C2 |
| MIXED METAL COMPOUNDS APPLICABLE AS ANTACIDS | 2008 |
|
RU2596489C2 |
| PHARMACEUTICAL SOLID PREPARATION CONTAINING BENZAZEPIN AND METHOD FOR PREPARING IT | 2008 |
|
RU2466717C2 |
| MIXED METAL COMPOUNDS APPLICABLE AS ANTACIDS | 2008 |
|
RU2510265C2 |
